576
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical test on circulating tumor cells in peripheral blood of lung cancer patients, based on novel immunomagnetic beads

, , , , &
Pages 892-897 | Received 10 Nov 2014, Accepted 06 Dec 2014, Published online: 14 Feb 2015

References

  • Bevilacqua S, Gallo M, Franco R, Rossi A, De Luca A, Rocco G, et al. 2009. A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer. 65:123–125.
  • Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. 2009. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 20: 1223–1229.
  • Okegawa T, Nutahara K, Higashihara E. 2009. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol. 181:1091–1097.
  • Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, et al. 2011. A direct comparison of CellSearch and ISET for circulating tumor-cells detection in patients with metastatic carcinomas. Br J Cancer. 105:847–853.
  • Hoeppener AE, Swennenhuis JF, Terstappen LW. 2012. Immunomagnetic separation technologies. Recent Results Cancer Res. 195:43–48.
  • Hou JM, Matthew K, Tim W, Robert S, Lynsey P, Andrew H, et al. 2011. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol. 178:989–996.
  • Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, et al. 2009. Circulating prostate tumor cells detected by RT-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastasis and with survival. Clin Chem. 55:765–773.
  • Huang TH, Wang Z, Li Q, Qi H, Zhou HX, Li FR. 2007. Clinical significance of nano immunomagnetic beads enrichment and test of circulating tumor cells in patients with non-small cell carcinoma. Chin J Oncol. 29:676–680.
  • Jiang WF, Zang HL. 2011. Enrichment and detection of circulating tumor cells in peripheral blood. Chin Ger J Clin Oncol. 10:240–244.
  • Riethdort S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al. 2007. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 13:920–928.
  • Schmitt M, Foekens JA. 2009. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells. Breast Cancer Res. 11:109.
  • Wulfing P, Borchard J, Buerger H, Heidl S, Zänker KS, Kiesel L, Brandt B. 2006. HER-2 positive circulating tumor cells indicate poor clinical outcome in stage I t o III breast cancer patients. Clin Cancer Res. 12:1715.
  • Weissenstein U, Schumann A, Reif M, Link S, Toffol-Schmidt UD, Heusser P. 2012. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies. BMC Cancer. 12:206.
  • Yu M, Stott S, Toner M, Maheswaran S, Haber DA. 2011. Circuling tumor cells: approaches to isolation and characterization. J Cell Bilo. 192:373–382.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.